Biomerica Insider Trades
NASDAQ: BMRAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $158.00K
- Sales
- 0 · $0
- Shares bought / sold
- 98.75K / 0
- Net activity
- Net buying $158,000
Biomerica insider activity
Over the last 12 months, Biomerica insiders reported 11 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $158,000 and sold $0 worth of stock, for net insider buying of $158,000. The most recent filing shows MOATAZEDI DAVID (Director) buying 10,000 shares at $1.60 on Aug 26, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BMRA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BMRA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 26, 2026 | Irani Zackary S.Chief Executive Officer | Buy | 31,250 | $50.00K | Form 4 |
| Aug 26, 2026 | BARBIERI ALLENExecutive Vice Chairman | Buy | 20,000 | $32.00K | Form 4 |
| Aug 26, 2026 | Chin EricDirector | Buy | 6,250 | $10.00K | Form 4 |
| Aug 26, 2026 | MOATAZEDI DAVIDDirector | Buy | 10,000 | $16.00K | Form 4 |
| Aug 20, 2026 | Gary M. HuffDirector | Buy | 31,250 | $50.00K | Form 4 |
| Dec 12, 2025 | MOATAZEDI DAVIDDirector | Award | 20,000 | — | Form 4 |
| Dec 12, 2025 | Gary M. HuffDirector | Award | 20,000 | — | Form 4 |
| Dec 12, 2025 | BARBIERI ALLENExecutive Vice-Chairman | Award | 30,000 | — | Form 4 |
| Dec 12, 2025 | Irani Zackary S.Chief Executive Officer | Award | 52,500 | — | Form 4 |
| Dec 12, 2025 | Lu GaryChief Financial Officer | Award | 40,000 | — | Form 4 |
| Dec 12, 2025 | Chin EricDirector | Award | 22,500 | — | Form 4 |
| Dec 13, 2024 | Lu GaryChief Financial Officer | Award | 155,000 | $48.05K | Form 4 |
| Dec 13, 2024 | Irani Zackary S.Chief Executive Officer | Award | 250,000 | $77.50K | Form 4 |
| Dec 13, 2024 | Emerson JaneDirector | Award | 85,000 | $26.35K | Form 4 |
| Dec 13, 2024 | Coste CatherineDirector | Award | 85,000 | $26.35K | Form 4 |
| Dec 13, 2024 | BARBIERI ALLENExecutive Vice Chairman | Award | 110,000 | $34.10K | Form 4 |
| Dec 13, 2024 | MOATAZEDI DAVIDDirector | Award | 85,000 | $26.35K | Form 4 |
| May 25, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 200 | $310 | Form 4 |
| May 24, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 500 | $805 | Form 4 |
| May 12, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 1,700 | $1.99K | Form 4 |
| May 10, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 500 | $635 | Form 4 |
| May 9, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 300 | $417 | Form 4 |
| May 4, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 1,000 | $1.36K | Form 4 |
| Apr 28, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 1,800 | $2.41K | Form 4 |
| Apr 27, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 2,600 | $3.41K | Form 4 |
| Apr 26, 2023 | Irani Zackary S.Chief Executive Officer | Buy | 7,000 | $8.82K | Form 4 |
| Jan 27, 2023 | BARBIERI ALLENExecutive Vice Chairman | Buy | 1,538 | $4.52K | Form 4 |
| Jan 26, 2023 | Coste CatherineDirector | Buy | 2,190 | $6.48K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4